From single to combinatorial therapies in spinal cord injuries for structural and functional restoration.
Ernesto Doncel-PérezGabriel Guízar-SahagúnIsrael GrijalvaPublished in: Neural regeneration research (2024)
Spinal cord injury results in paralysis, sensory disturbances, sphincter dysfunction, and multiple systemic secondary conditions, most arising from autonomic dysregulation. All this produces profound negative psychosocial implications for affected people, their families, and their communities; the financial costs can be challenging for their families and health institutions. Treatments aimed at restoring the spinal cord after spinal cord injury, which have been tested in animal models or clinical trials, generally seek to counteract one or more of the secondary mechanisms of injury to limit the extent of the initial damage. Most published works on structural/functional restoration in acute and chronic spinal cord injury stages use a single type of treatment: a drug or trophic factor, transplant of a cell type, and implantation of a biomaterial. Despite the significant benefits reported in animal models, when translating these successful therapeutic strategies to humans, the result in clinical trials has been considered of little relevance because the improvement, when present, is usually insufficient. Until now, most studies designed to promote neuroprotection or regeneration at different stages after spinal cord injury have used single treatments. Considering the occurrence of various secondary mechanisms of injury in the acute and sub-acute phases of spinal cord injury, it is reasonable to speculate that more than one therapeutic agent could be required to promote structural and functional restoration of the damaged spinal cord. Treatments that combine several therapeutic agents, targeting different mechanisms of injury, which, when used as a single therapy, have shown some benefits, allow us to assume that they will have synergistic beneficial effects. Thus, this narrative review article aims to summarize current trends in the use of strategies that combine therapeutic agents administered simultaneously or sequentially, seeking structural and functional restoration of the injured spinal cord.
Keyphrases
- spinal cord
- spinal cord injury
- neuropathic pain
- liver failure
- clinical trial
- drug induced
- respiratory failure
- mental health
- aortic dissection
- healthcare
- stem cells
- oxidative stress
- public health
- cancer therapy
- risk assessment
- hepatitis b virus
- emergency department
- heart rate variability
- intensive care unit
- brain injury
- mesenchymal stem cells
- climate change
- autism spectrum disorder
- young adults
- cell therapy
- social media
- phase iii
- chemotherapy induced
- blood pressure
- childhood cancer